Combined with platinum-based chemotherapy, BEZ235 dramatically potentiated NSCLC cell death by suppressing Chk1 and Chk2, enhancing or prolonging DNA damage, and inducing apoptosis. This evidence concerns the gene CHEK1 and non-small cell lung carcinoma.